問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of Infectious Disease

Division of General Surgery

Division of Colorectal Surgery

更新時間：2023-09-19

蔡元耀
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

Recruiting Trial

10Cases

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

蔡元耀

List

15Cases

2019-09-30 - 2021-07-27

Phase II

A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis

  • Condition/Disease

    Moderately to Severely Active Ulcerative Colitis

  • Test Drug

    Brazikumab (AMG 139)

Participate Sites
6Sites

Not yet recruiting6Sites

2018-11-01 - 2019-10-31

Phase III

A prospective, randomized, evaluator blind, active-controlled, parallel study of the efficacy and safety of Quiklean® and Klean-Prep with Dulcolax® for the bowel preparation prior to colonoscopy

  • Condition/Disease

    bowel preparation in subjects undergoing colonoscopy

  • Test Drug

    Quiklean

Participate Sites
2Sites

Terminated1Sites

Study ended1Sites

陳自諒
China Medical University Hospital

Division of Colorectal Surgery

2021-10-20 - 2025-04-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2020-06-12 - 2022-09-01

Phase III

A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection vs. Intravenous Caspofungin Followed by Oral Fluconazole Step Down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

  • Condition/Disease

    Candidemia and/or Invasive Candidiasis

  • Test Drug

    Rezafungin

Participate Sites
5Sites

Not yet recruiting4Sites

Terminated1Sites

2018-06-01 - 2027-06-30

Phase II/III

A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  • Condition/Disease

    Moderately to Severely Active Crohn's Disease

  • Test Drug

    guselkumab

Participate Sites
4Sites

Recruiting4Sites

1 2
聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB